NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Saguaro Biosciences

Saguaro Biosciences

Private
QuebecHealthcare & Life Scienceshttps://www.saguarobio.com/

Last Round

Grant

Nov 11, 2025

Total Funding Raised

$4.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Saguaro Biosciences is a biotechnology company that develops a live-cell image-based profiling platform designed to accelerate drug discovery and life sciences research.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

live-cell imagingnon-toxic dyescell imaging reagentsfluorescent dyeslive cell stainsdrug discovery toolsphenotypic screeningcell paintinghigh-throughput screeningdrug profiling servicehigh-content imagingorganoid imaging3D cell culturecytotoxicity assayscompound screeningAI-enabled analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Saguaro Biosciences Comparables

Compare Saguaro Biosciences with similar companies based on industry and business-model similarity.

Saguaro Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Saguaro Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 11, 2025
SeedJun 4, 2024
Pre SeedFeb 16, 2022

Key People

Founding team and executive leadership

Felix Lavoie-Perusse

Co-Founder And Chief Commercial Officer (CCO)

Founding Team

Louis Turcotte

CEO And Co-founder

Founding Team

Saguaro Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 26, 2026

    Monthly visitors increased 551% MoM.

  • Jan 6, 2026

    Monthly visitors grew 87% MoM.

Saguaro Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Saguaro Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Saguaro Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersQuebec
Employee Range15
Year Founded2020
Last FundingNov 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.